Literature DB >> 31558559

Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703-1714.

.   

Abstract

Entities:  

Year:  2019        PMID： 31558559      PMCID： PMC6764272          DOI： 10.1182/blood.2019002852

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
In the last sentence of the first paragraph under “SS” on page 1704, “CD4+/CD7− cells ≥30%, or CD4+/CD26− cells ≥40%” should read “CD4+/CD7− cells ≥40%, or CD4+/CD26− cells ≥30%.” The errors have been corrected in the online version of the article.
  4 in total

1.  The impact of gender, age, race/ethnicity, and stage on quality of life in a spectrum of cutaneous lymphomas.

Authors:  Xochiquetzal U Martinez; Arnab Chowdhury; Tracey Stiller; Joycelynne Palmer; Matthew Loscalzo; Estella Barrios; Farah R Abdulla; Jasmine Zain; Steven T Rosen; Christiane Querfeld
Journal:  Support Care Cancer       Date:  2021-05-07       Impact factor: 3.603

Review 2.  The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradication.

Authors:  Joseph S Durgin; David M Weiner; Maria Wysocka; Alain H Rook
Journal:  J Am Acad Dermatol       Date:  2020-12-22       Impact factor: 11.527

3.  Ki67 and CD31 Differential Expression in Cutaneous T-Cell Lymphoma and Its Mimickers: Association with Clinicopathological Criteria and Disease Advancement.

Authors:  Marwa Zohdy; Amal Abd El Hafez; Mona Younis Youssef Abd Allah; Hagar Bessar; Sherine Refat
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-06-23

4.  Editorial: Cutaneous B-Cell Lymphomas.

Authors:  Mauro Alaibac; Deniz Seckin; Pietro Quaglino
Journal:  Front Oncol       Date:  2020-12-09       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.